Crohn's & Colitis UK
Web page
Mar 2022
Patients and professionals
Reports a University of Nottingham study, funded by the charity and Coeliac UK, that looked at GP records for 38.3 million people. It found more than half a million people in the UK, about 1 in every 123, live with Crohn's, ulcerative colitis or unclassified IBD, almost twice the previous estimate of 300,000.
Topics
About Crohn's disease
Research
Jargon explained
prevalence
incidence
BMJ Open via PubMed Central
Study
Jul 2020
For professionals
A study of more than 11 million people's GP records from 2000 to 2018 tracking new IBD diagnoses in the UK. It found new cases in adults were stable or falling, but UK rates are among the highest reported anywhere, with a large rise in new diagnoses among teenagers.
Topics
About Crohn's disease
Research
Jargon explained
incidence
prevalence
cohort study
primary care
BMC Gastroenterology
Data
Mar 2021
For professionals
Another big UK GP-records study, covering 2006 to 2016. It found IBD rose by about a third over that time to roughly 1.4% of patients, higher than earlier estimates. The authors point out that the answer depends heavily on how a 'case' is defined, which may explain why older figures were lower.
Topics
About Crohn's disease
Research
Jargon explained
retrospective cohort study
prevalence
incidence
The Lancet
Systematic review
Dec 2017
For professionals
A review of population studies from around the world. In Western countries the number of new cases is levelling off but more than 0.3% of people now live with IBD. In newly industrialised countries in Asia, Africa and South America, new cases are rising quickly as lifestyles become more Western.
Topics
About Crohn's disease
Research
Jargon explained
systematic review
incidence
prevalence
population-based study
NICE Clinical Knowledge Summaries
Guide
May 2024
For professionals
NICE's GP summary on how common Crohn's is. It says exact figures are not known because studies count cases differently, that new cases are thought to be stable or falling in Europe and the US but rising in newly industrialised countries, and that Crohn's usually starts in the teenage and young adult years, with a median age at diagnosis of about 30. Men and women are affected about equally.
Topics
About Crohn's disease
Research
Jargon explained
incidence
prevalence
New England Journal of Medicine
Study
May 2023
Patients and professionals
Three trials of upadacitinib (Rinvoq), a daily tablet rather than an injection or drip. It worked better than placebo both for settling active Crohn's over 12 weeks and for keeping it settled over a year. Some side effects, such as liver changes, low white cells and a few cases of bowel perforation, were seen more on the drug, so it needs monitoring.
Topics
Medicines
Immunosuppressants
Research
Jargon explained
JAK inhibitor
small molecule
induction
maintenance
herpes zoster
endoscopic response
Alimentary Pharmacology & Therapeutics
Data
May 2020
Patients and professionals
Using UK GP records from 2000 to 2017, this study found Crohn's became more common, rising from about 220 to 400 per 100,000 people. It predicted about 1 in 90 people in the UK would have IBD by 2025. Colitis was linked to a higher risk of bowel cancer, and both conditions to a somewhat higher risk of death than people without IBD.
Topics
About Crohn's disease
Cancer risk and screening
Research
Jargon explained
epidemiology
prevalence
hazard ratio
all-cause mortality
The Lancet Gastroenterology & Hepatology via PubMed Central
Study
Oct 2019
For professionals
Part of the Global Burden of Disease project, estimating about 6.8 million people with IBD worldwide in 2017. Rates were highest in wealthier countries, and the UK had the second highest age-adjusted rate after the USA.
Topics
About Crohn's disease
Research
Jargon explained
prevalence
inflammatory bowel disease
disability-adjusted life years
age-standardised rate